Chang PC - Search Results

1

The angiotensin-converting enzyme genotype and microalbuminuria in autosomal dominant polycystic kidney disease.

van Dijk MA, Peters DJ, Breuning MH, Chang PC. van Dijk MA, et al. Among authors: chang pc. J Am Soc Nephrol. 1999 Sep;10(9):1916-20. doi: 10.1681/ASN.V1091916. J Am Soc Nephrol. 1999. PMID: 10477143

2

Autosomal-dominant polycystic kidney disease and hypertension: a review.

Florijn KW, van Saase JL, Breuning MH, Chang PC. Florijn KW, et al. Among authors: chang pc. Contrib Nephrol. 1992;97:71-92. doi: 10.1159/000421646. Contrib Nephrol. 1992. PMID: 1386018 Review. No abstract available.

3

A century of mortality in five large families with polycystic kidney disease.

Florijn KW, Noteboom WM, van Saase JL, Chang PC, Breuning MH, Vandenbroucke JP. Florijn KW, et al. Among authors: chang pc. Am J Kidney Dis. 1995 Mar;25(3):370-4. doi: 10.1016/0272-6386(95)90096-9. Am J Kidney Dis. 1995. PMID: 7872313

4

Intracranial aneurysms in polycystic kidney disease linked to chromosome 4.

van Dijk MA, Chang PC, Peters DJ, Breuning MH. van Dijk MA, et al. Among authors: chang pc. J Am Soc Nephrol. 1995 Dec;6(6):1670-3. doi: 10.1681/ASN.V661670. J Am Soc Nephrol. 1995. PMID: 8749697

5

The angiotensin-converting enzyme gene polymorphism and responses to angiotensins and bradykinin in the human forearm.

van Dijk MA, Kroon I, Kamper AM, Boomsma F, Danser AH, Chang PC. van Dijk MA, et al. Among authors: chang pc. J Cardiovasc Pharmacol. 2000 Mar;35(3):484-90. doi: 10.1097/00005344-200003000-00020. J Cardiovasc Pharmacol. 2000. PMID: 10710136 Clinical Trial.

6

The ACE insertion/deletion polymorphism has no influence on progression of renal function loss in autosomal dominant polycystic kidney disease.

van Dijk MA, Breuning MH, Peters DJ, Chang PC. van Dijk MA, et al. Among authors: chang pc. Nephrol Dial Transplant. 2000 Jun;15(6):836-9. doi: 10.1093/ndt/15.6.836. Nephrol Dial Transplant. 2000. PMID: 10831637

7

Long-term cardiovascular morbidity and mortality in autosomal dominant polycystic kidney disease patients after renal transplantation.

Florijn KW, Chang PC, van der Woude FJ, van Bockel JH, van Saase JL. Florijn KW, et al. Among authors: chang pc. Transplantation. 1994 Jan;57(1):73-81. doi: 10.1097/00007890-199401000-00014. Transplantation. 1994. PMID: 8291117

8

Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion.

Barendregt JN, Florijn KW, Muizert Y, Chang PC. Barendregt JN, et al. Among authors: chang pc. Nephrol Dial Transplant. 1995;10(8):1332-41. Nephrol Dial Transplant. 1995. PMID: 8538923

9

Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage.

van de Wetering J, Westendorp RG, van der Hoeven JG, Stolk B, Feuth JD, Chang PC. van de Wetering J, et al. Among authors: chang pc. J Am Soc Nephrol. 1996 Jan;7(1):145-50. doi: 10.1681/ASN.V71145. J Am Soc Nephrol. 1996. PMID: 8808122

10

Glomerular filtration rate measurement by "single-shot" injection of inulin.

Florijn KW, Barendregt JN, Lentjes EG, van Dam W, Prodjosudjadi W, van Saase JL, van Es LA, Chang PC. Florijn KW, et al. Among authors: chang pc. Kidney Int. 1994 Jul;46(1):252-9. doi: 10.1038/ki.1994.267. Kidney Int. 1994. PMID: 7933844 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

805 results

Search Page

Filters